Allstate reports Q2 results on August 5 with the stock up 11% over the past month to $264.08 — yet options traders have quietly grown more defensive since the July 29 print.
The clearest shift in positioning is in the options market. The put/call ratio has climbed to 1.46, above its 20-day average of 1.43 and near the top of its recent range. That's a notable move given how relaxed the ratio was in late June and early July, when it traded closer to 1.02–1.08. The borrow market, by contrast, tells a calm story. Availability remains extremely loose at roughly 1,687% — more than 16 shares available in the lending pool for every one currently borrowed — and the cost to borrow is negligible at 0.47%. Short interest itself has drifted lower again, easing another 15% over the past month to 3.0% of the free float, broadly consistent with the prior preview. Shorts are not the story heading into this print.
The debate sits squarely with the analysts and the valuation. Most firms raised targets ahead of the July earnings cycle, with JP Morgan lifting to $282 and Raymond James pushing to $300 — both maintaining positive ratings. But two downgrades arrived at the same time: UBS moved to Neutral (raising its target to $261) and HSBC stepped back to Hold. The consensus mean target of $255 now sits below where the stock is trading at $264, implying analysts as a group see modest downside from here. Bulls point to accelerating policy-in-force growth in personal auto and favorable loss reserve developments as evidence the underwriting recovery is real. Bears flag that the combined ratio of 89.4% remains well above the company's own 95% long-term target, and that intensifying competition in personal lines could pressure pricing. The EV/EBITDA multiple has ticked down over the past week, but the PE has expanded 30 days running — a sign the market is pricing in continued improvement that the bears argue isn't yet fully delivered.
Among peers, ALL is an outlier this week. CB fell 2.5%, TRV dropped 3.3%, WRB slid 3.9%, and ACGL lost 2.7%. THG bucked the trend, rising 6.7%, but Allstate's 1.6% weekly gain is notably resilient relative to the broader group. The prior July 29 print produced a one-day decline of 2.6%, a reaction that has since been fully absorbed by the market.
The August 5 report will test whether Allstate's underwriting margins are genuinely inflecting, or whether the stock's re-rating — now running ahead of the analyst consensus — has borrowed too much from future improvement.
See the live data behind this article on ORTEX.
Open ALL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
